Pitfalls in Diagnosis of Myoepithelial Carcinoma of Salivary Glands: A Study of 3 Cases with Cytologic-histologic Correlation and Molecular Analysis.


Journal

Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 22 07 2024
accepted: 28 08 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 14 10 2024
Statut: epublish

Résumé

Myoepithelial carcinoma (MECA) represents < 1% percent of salivary gland (SG) tumors with a mean age of 55 years. These tumors can arise de novo or in association with pre-existing pleomorphic Adenoma (PA). The cytologic features of MECA overlap with other SG neoplasms including the more common benign entities like PA and myoepithelioma and can pose a diagnostic challenge. A database search for MECA was performed spanning 10 years. 3 cases qualified with available cyto-histologic correlation. All were morphologically MECA with one case diagnosed as MECA ex-PA. The cases were subjected to a comprehensive immunohistochemical and molecular evaluation (Case#1 has been previously reported and published in head and neck pathology in 2021). A comparative analysis of these cases is presented in Table 1. All three cases were initially diagnosed as PA on cytology. On review of cytology slides, presence of metachromatic stromal fragments and bland myoepithelial cells was found to be the most common diagnostic pitfall. S100 was positive in all cases while myosin, p63, and GFAP were variably positive. Molecular analysis revealed novel, previously undescribed mutations in the three cases. Additionally, two of three cases expressed PD-L1, suggesting a role for immunotherapy in treatment. Cytomorphology of MECA is poorly described in literature and can pose a diagnostic challenge due to overlapping features with salivary gland benign neoplasms. A conclusive diagnosis on cytology is often not possible. However, a high cellularity, predominant oncocytoid/ myoepithelial cell population on smears and cell block, along with a strong clinical and radiologic suspicion for malignant salivary gland tumor, should alert the cytopathologist and help avoid an erroneous benign diagnosis on cytology.

Identifiants

pubmed: 39402432
doi: 10.1007/s12105-024-01698-3
pii: 10.1007/s12105-024-01698-3
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

96

Subventions

Organisme : University of New Mexico
ID : Department funds

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Cormier C, Agarwal S (2022) Myoepithelial Carcinoma Ex-pleomorphic Adenoma: a Rare Pathology misdiagnosed as Pleomorphic Adenoma; with a novel TERT promoter mutation and high PD-L1 expression. Head Neck Pathol 16(1):322–330
doi: 10.1007/s12105-021-01346-0 pubmed: 34128136
Xu B, Mneimneh W, Torrence DE et al (2019) Misinterpreted myoepithelial carcinoma of salivary gland: a challenging and potentially signifcant pitfall. Am J Surg Pathol 43(5):601–609. https://doi.org/10.1097/PAS.0000000000001218
doi: 10.1097/PAS.0000000000001218 pubmed: 30789358 pmcid: 7480003
Brenda L, Nelson, Thompson LDR (2022) Myoepithelial carcinoma. In: Diagnostic Pathology, Head and neck, 3rd Edition. Philadeplphia: Elsevier; pp. 636–639
Said S, Campana J (2005) Myoepithelial carcinoma ex pleomorphic adenoma of salivary glands: a problematic diagnosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99:196–201
doi: 10.1016/j.tripleo.2003.11.014 pubmed: 15660092
Brandwein-Gensler M, Bell D, Inagaki H, Katabi N, Leivo I, Seethala R, Triantafyllou A (2005) Malignant tumours of the salivary gland. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (eds) World Health Organization classification of Head and Neck tumors. IARC, Lyon, pp 160–184
Kong M, Drill EN, Morris L et al (2015) Prognostic factors in myoepithelial carcinoma of salivary glands: a clinicopathologic study of 48 cases. Am J Surg Pathol 39(7):931–938
doi: 10.1097/PAS.0000000000000452 pubmed: 25970687 pmcid: 4939272
Argyris PP, Wakely PE Jr (2023 Nov-Dec) Cytopathology of salivary gland myoepithelial carcinoma: a study of 13 cases and review of the literature. J Am Soc Cytopathol 12(6):461–468
Darvishian F, Lin O (2004) Myoepithelial cell-rich neoplasms: cytologic features of benign and malignant lesions. Cancer 102(6):355–361
doi: 10.1002/cncr.20642 pubmed: 15476290
Guo X, Watanabe J, Ariyasu S, Sasaguri Y, Kurose N, Fukushima K, Yamada S (2018) Myoepithelial carcinoma of the parotid gland: a case of adequate fine-needle aspiration cytology specimens rendering a conclusive diagnosis possible. SAGE Open Med Case Rep 6:2050313X18780842
doi: 10.1177/2050313X18780842 pubmed: 29899989 pmcid: 5990880
DiPalma S, Alasio L, Pilotti S (1996) Fine needle aspiration (FNA) appearances of malignant myoepithelioma of the parotid gland. Cytopathology 7:357–365
doi: 10.1111/j.1365-2303.1996.tb00315.x pubmed: 8911760
Chhieng DC, Paulino AF (2002) Cytology of myoepithelial carcinoma of the salivary gland. Cancer 96:32–36
doi: 10.1002/cncr.10314 pubmed: 11836700
Sehgal S, Goyal P, Singh S, Kumar A (2013) Fine-needle aspiration cytology of myoepithelial carcinoma of salivary gland: diagnostic challenge to cytopathologist. J Cytol 30(3):207–210
doi: 10.4103/0970-9371.117648 pubmed: 24130417 pmcid: 3793362
Xu B, Katabi N (2021) Myoepithelial Carcinoma. Surg Pathol Clin 14(1):67–73. https://doi.org/10.1016/j.path.2020.09.008 Epub 2021 Jan 5
doi: 10.1016/j.path.2020.09.008 pubmed: 33526224 pmcid: 8522910
Savera AT, Sloman A, Huvos AG, Klimstra DS (2000) Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol 24(6):761–774. https://doi.org/10.1097/00000478-200006000-00001
doi: 10.1097/00000478-200006000-00001 pubmed: 10843278
Dalin MG, Katabi N, Persson M et al (2017) Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions. Nat Commun 8:1197
doi: 10.1038/s41467-017-01178-z pubmed: 29084941 pmcid: 5662567
Skálová A, Weinreb I, Hyrcza M, Simpson RH, Laco J, Agaimy A, Vazmitel M, Majewska H, Vanecek T, Talarčik P, Manajlovic S, Losito SN, Šteiner P, Klimkova A, Michal M (2015) Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol 39(3):338–348
doi: 10.1097/PAS.0000000000000364 pubmed: 25581728
Bahrami A, Dalton JD, Shivakumar B et al (2012) PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases. Head Neck Pathol 6:328–335. https://doi.org/10.1007/s12105-012-0353-8
doi: 10.1007/s12105-012-0353-8 pubmed: 22485045 pmcid: 3422590
Chiba K, Johnson JZ, Vogan JV, Wagner T, Boyle JM, Hockemeyer D (2015) Cancer-associated TERT promoter mutations abrogate telomerase silencing. Elife 4:e07918
doi: 10.7554/eLife.07918 pubmed: 26194807 pmcid: 4507476
Shigeishi H, Sugiyama M, Tahara H, Ono S, Kumar Bhawal U, Okura M, Kogo M, Shinohara M, Shindoh M, Shintani S, Hamakawa H, Takata T, Kamata N (2011) Increased telomerase activity and hTERT expression in human salivary gland carcinomas. Oncol Lett 2(5):845–850
pubmed: 22866138 pmcid: 3408017
Owosho AA, Adesina OM, Odujoko O, Akinyemi H, Komolafe A, Tadros S, Bauer R, Summersgill KF (2022) HMGA2 immunoexpression is frequent in salivary gland pleomorphic adenoma: immunohistochemical and molecular analyses of PLAG1 and HMGA2 in 25 cases. Int J Clin Exp Pathol 15(2):63–71
pubmed: 35265254 pmcid: 8902481
Asahina M, Saito T, Hayashi T, Fukumura Y, Mi tani K, Yao T (2019) Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features. Histopathology 74:514–525
doi: 10.1111/his.13759 pubmed: 30307055
Mukaigawa T, Hayashi R, Hashimoto K et al (2016) Programmed death ligand-1 expression is associated with poor disease-free survival in salivary gland carcinomas. J Surg Oncol 114:36–43
doi: 10.1002/jso.24266 pubmed: 27111278
Elsheikh TM, Bernacki EG (1996) Fine needle aspiration cytology of cellular pleomorphic adenoma. Acta Cytol 40:1165e1175
doi: 10.1159/000333976
Bijan Khademi T, Kazemi A, Bayat H, Bahranifard Y, Daneshbod (2010) Mohammad Mohammadianpanah; salivary gland Myoepithelial neoplasms: a clinical and cytopathologic study of 15 cases and review of the literature. Acta Cytol 1 Dec 54(6):1111–111726
Baloch Z, Fadda G, Griffith CG et al (2023) Neoplasms. In: WC Faquin, ED Rossi, Z Baloch, eds. The Milan System for Reporting Salivary Gland Cytopathology. Springer; 2nd edition

Auteurs

Shweta Agarwal (S)

Department of Laboratory Medicine and Pathology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. Agarwal.shweta@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH